Anti-basement membrane zone antibodies in elderly patients with pruritic disorders and diabetes mellitus

European Journal of Dermatology

Volumn 18, Issue 5, 2008, Pages 534-538

  Jedlickova, Hana ^a,b   Racovska, Jana ^a,b   Niedermeier, Andrea ^c   Feit, Josef ^a   Hertl, Michael ^c  

^a MASARYK UNIVERSITY   (Czech Republic)

^b ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Anti basement membrane zone antibody; Bullous pemphigoid; Diabetes mellitus; ELISA; Indirect immunofluorescence

Indexed keywords

ANTIGEN; BASEMENT MEMBRANE ANTIBODY; BP 180 PROTEIN; BULLOUS PEMPHIGOID ANTIGEN 1; IMMUNOGLOBULIN G; KALININ; UNCLASSIFIED DRUG;

AGE; AGED; ANTIBODY DETECTION; ANTIBODY LABELING; ARTICLE; BASAL CELL; BASEMENT MEMBRANE; BULLOUS PEMPHIGOID; CELL MEMBRANE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; RISK ASSESSMENT; RISK FACTOR; SEROLOGY; SKIN PRURITUS;

AGED; AUTOANTIBODIES; BASEMENT MEMBRANE; DIABETES MELLITUS; HUMANS; PRURITUS;

EID: 52649164696     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: 10.1684/ejd.2008.0483     Document Type: Article

References (33)

1. Bornhövd E, Partscht K, Flaig MJ, Messer G. Bullöse skabiesbefall getriggertes bullöses pemphigoid. Hautarzt 2001; 52: 56-61.
2. Gengoux P, Lachapelle JM. Pemphigoid presenting as atypical excoriated prurigo. Regarding 11 cases. Dermatology 1997; 194: 392-4.
3. Laffitte E, Borradori L. Bullous pemphigoid. Challenging situations. In: Hertl M, ed. Autoimmune diseases of the skin, 1st ed. Wien New York: Springer, 2005: 71-93.
4. Yancey KB. The pathophysiology of autoimmune blistering diseases. J Clin Invest 2005; 115: 825-8.
5. Jedlickova H, Vlasin Z. Bullous pemphigoid and internal diseases. Abstracts of the 11th Congress of the EADV Prague, JEADV suppl 1 2002; 16: 24.
6. Vohradníková O, Perusicová J. Prehled soucasné problematiky diabetického syndromu. In: Skin manifestations of diabetes mellitus. 1st ed. Prague: Maxdorf, 1996: 15-9.
7. Warram JH, Krolewski AS. Epidemiology of Diabetes mellitus. In: Kahn CR, Weir GC, King GIL, Moses AC, Smith RJ, Jacobson AM, eds. Joslin's Diabetes mellitus, 14th ed. Lippincott, Williams & Wilkins, 2004: 115-27.
8. Rosina P, Chieregato C, D'Onghia FS. Bullous pemphigoid and diabetes mellitus. Acta Derm Venereol 1996; 76: 497-8.
9. Chuang TY, Korkij W, Soltani K, Clayman J, Cook J. Increased frequency of diabetes mellitus in patients with bullous pemphigoid: a case-control study. J Am Acad Dermatol 1984; 11: 1099-102.
10. Turk Z, Mišur I, Turk N, Benko B. Rat tissue collagen modified by advanced glycation: correlation with duration of diabetes and glycemic control. Clin Chem Lab Med 1999; 37: 813-20.
11. Al-Mutairi N, Zaki A, Sharma AK, Al-Sheltawi M. Cutaneous manifestations of diabetes mellitus. Study from Farwaniya hospital, Kuwait. Med Princ Pract 2006; 15: 427-30.
12. Bhat YJ, Gupta V, Kudyar RP. Cutaneous manifestations of diabetes mellitus. Int J Diab Dev Ctries 2006: 26: 152-5.
13. Neilly JB, Martin A, Simpson N, MacCuish AC. Pruritus in diabetes mellitus: investigation of prevalence and correlation with diabetes control. Diabetes Care 1986; 9: 273-5.
14. Wohlrab J, Wohlrab D, Meiss F. Skin diseases in diabetes mellitus. J Dtsch Dermatol Ges 2007; 5: 37-53.
15. Toonstra J. Bullosis diabeticorum. Report of a case with a review of the literature. J Am Acad Dermatol 1985; 13: 799-805.
16. Hofmann SC, Tamm K, Hertl M, Borradori L. Diagnostic value of an enzyme-linked immunosorbent assay using BP180 recombinant proteins in elderly patients with pruritic skin disorders. Br J Dermatol 2003; 149: 910-2.
17. Thoma-Uszynski S, Uter W, Schwietzke S, Hofmann SC, Hunziker T, Bernard P, Treudler R, Zouboulis CC, Schuler G, Borradori L, Hertl M. BP230- and BP180-specific auto-antibodies in bullous pemphigoid. J Invest Dermatol 2004; 122: 1413-22.
18. Bekou V, Thoma-Uszynski S, Wendler O, Uter W, Scwietzke S, Hunziker T, Zouboulis CC, Schuler G, Sorokin L, Hertl M. Detection of laminin 5-specific auto-antibodies in mucous membrane and bullous pemphigoid sera by ELISA. J Invest Dermatol 2005; 124: 732-40.
19. Andersen-Ranberg K, Høier-Madsen M, Wiik A, Jeune B, Hegedüs L. High prevalence of autoantibodies among Danish centenarians. Clin Exp Immunol 2004; 138: 158-63.
20. Nilsson B-O, Skogh T, Ernerudh J, Johansson B, Löfgren S, Wikby A, Dahle C. Antinuclear antibodies in the oldest-old women and men. J Autoimmun 2006; 27: 281-8.
21. Rieckhoff-Cantoni L, Bernard P, Didierjean L, Imhof K, Kinlochde-Loes S, Saurat J-H. Frequency of bullous pemphigoid-like antibodies as detected by western immunoblot analysis in pruritic dermatoses. Arch Dermatol 1992; 128: 791-4.
22. Davies MG, Pembroke AC, Bhogal B, Davies E, Vergani D. Circulating basement membrane zone antibodies in eczema. Clin Exp Dermatol 1984; 9: 36-41.
23. Hachisuka H, Kurose K, Karashima T, Mori O, Maeyama Y. Serum from normal elderly individuals contains anti-basement membrane zone antibodies. Arch Dermatol 1996; 132: 1201-5.
24. Nakagawa A, Kobayashi N, Yamashina Y, Nakatani C, Muramatsu T, Mori T, Shirai T. Effect of nonenzymatic glycosylation on the titers of circulating autoantibodies in pemphigus and pemphigoid. J Dermatol 1998; 25: 710-5.
25. van Joost T. Incidence of circulating antibodies reactive with basal cells of skin in drug reactions. Acta Derm Venereol 1974; 54: 183-7.
26. Ablin RJ, Holder IA. Antibodies to basal cells. J Invest Dermatol 1981; 76: 523.
27. Lin SC, Sun A, Wu YC, Chiang CP. Presence of anti-basal cell antibodies in oral lichen planus. J Am Acad Dematol 1992; 26: 943-7.
28. Nishikawa T, Kurihara S, Harado T, Hatano H. Binding of bullous pemphigoid antibodies to basal cells. J Invest Dermatol 1980; 74: 389-91.
29. Kitajima Y, Nojiri M, Yamada T, Hirako Y, Owaribe K. Internalization of the 180 kDa bullous pemphigoid antigen as immune complexes in basal keratinocytes: an important early event in blister formation in bullous pemphigoid. Br J Dermatol 1998; 138: 71-6.
30. Borradori L, Sonnenberg A. Structure and function of hemidesmosomes: more than simple adhesion complexes. J Invest Dermatol 1999; 112: 411-8.
31. Hofmann S, Thoma-Uszynski S, Hunziker T, Bernard P, Koebnick C, Stauber A, Schuler G, Borradori L, Hertl M. Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain. J Invest Dermatol 2002; 119: 1065-73.
32. Di Zenzo G, Grosso F, Terracina M, Mariotti F, De Pita O, Owaribe K, Mastrogiacomo A, Sera F, Borradori L, Zambruno G. Characterization of the anti-BP180 autoantibody reactivity profile and epitope mapping in bullous pemphigoid patients. J Invest Dermatol 2004; 122: 103-10.
33. Kainulainen T, Autio-Harmainen H, Oikarinen A, Solo S, Trygvason K, Salo T. Altered distribution and synthesis of laminin-5 (Kalinin) in oral lichen planus, epithelial dysplasias and squamous cell carcinomas. Br J Dermatol 1997; 136: 331-6.